SoftBank Group
PEAR

SoftBank Group’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

SoftBank Group’s Portfolio PEAR Stock Details PEAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-12,100,078
Closed -$3.09M – 31
2023
Q1 		$3.09M Buy
+12,100,078
New +$3.09M 0.04% 26